Covered recipient · General Payments record
MATTHEW STEVEN BERGSTEN
Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine
General Payments · PY2018–2024
$17,352.25
- Reported across 223 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $510.77 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $274.29 | 19 |
| Abbott Laboratories | $161.89 | 12 |
| BOSTON SCIENTIFIC CORPORATION | $28.84 | 1 |
| Avanos Medical | $16.72 | 1 |
| Ferring Pharmaceuticals Inc. | $14.79 | 1 |
| Curonix LLC | $14.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.82 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836793 | CMS |
| Abbott Laboratories | $6.03 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836796 | CMS |
| Abbott Laboratories | $12.93 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836800 | CMS |
| Abbott Laboratories | $13.19 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836804 | CMS |
| Abbott Laboratories | $12.90 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836808 | CMS |
| Abbott Laboratories | $10.48 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836811 | CMS |
| Abbott Laboratories | $21.73 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836815 | CMS |
| Abbott Laboratories | $16.84 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836819 | CMS |
| Abbott Laboratories | $16.15 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836834 | CMS |
| Abbott Laboratories | $8.90 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836823 | CMS |
| Abbott Laboratories | $13.09 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836827 | CMS |
| Abbott Laboratories | $12.83 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124836830 | CMS |
| ABBVIE INC. | $17.26 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312326 | CMS |
| ABBVIE INC. | $2.14 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312328 | CMS |
| ABBVIE INC. | $4.86 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312330 | CMS |
| ABBVIE INC. | $21.06 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312332 | CMS |
| ABBVIE INC. | $3.02 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312334 | CMS |
| ABBVIE INC. | $3.90 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312336 | CMS |
| ABBVIE INC. | $9.09 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312338 | CMS |
| ABBVIE INC. | $5.56 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312340 | CMS |
| ABBVIE INC. | $7.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312342 | CMS |
| ABBVIE INC. | $4.57 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312344 | CMS |
| ABBVIE INC. | $7.24 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312346 | CMS |
| ABBVIE INC. | $18.21 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312348 | CMS |
| ABBVIE INC. | $78.13 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312350 | CMS |
| ABBVIE INC. | $22.17 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312352 | CMS |
| ABBVIE INC. | $9.24 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312354 | CMS |
| ABBVIE INC. | $20.30 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312356 | CMS |
| ABBVIE INC. | $9.07 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312358 | CMS |
| ABBVIE INC. | $10.76 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312360 | CMS |
| ABBVIE INC. | $20.28 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103312362 | CMS |
| Avanos Medical | $16.72 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149304351 | CMS |
| Boston Scientific Corporation | $28.84 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092683943 | CMS |
| Curonix LLC | $14.24 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132905384 | CMS |
| Ferring Pharmaceuticals Inc. | $14.79 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137464659 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.